Axial Biotech is a privately held, venture-backed molecular diagnostics company focused on developing high-value tests that answer key clinical questions for orthopaedic surgeons. Axial has one product on the market: ScoliScore, a clinically validated, multi-gene test that accurately determines the likelihood of curve progression into a severe range for patients with Adolescent Idiopathic Scoliosis. Axial will generate $5.8M in sales in 2011.